2026 data ClinicalTrials.gov official source

Conditions: M

Every condition beginning with M that has a registered US clinical trial, with how many studies cover each.

2,127 conditions starting with "M"

Showing 1,501–1,550 of 2,127

Condition Trials
Moderate to Advanced Chronic Periodontitis 1
Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4) 1
Moderate to Severe Acne Vulgaris 1
Moderate to Severe Asthma 4
Moderate to Severe Chronic Kidney Disease 1
Moderate to Severe Chronic Plaque-Type Psoriasis 2
Moderate to Severe Crohn's Disease 1
Moderate to Severe Dysphagia 1
Moderate to Severe Genital Psoriasis 1
Moderate to Severe Glabellar Lines 2
Moderate to Severe Plaque Psoriasis 4
Moderate to Severe Psoriasis 1
Moderate to Severe Traumatic Brain Injury 1
Moderate to Very Severe COPD 1
Moderate Traumatic Brain Injury 2
Moderate Tricuspid Regurgitation 1
Moderate Valgus, Varus, or Flexion Deformities 1
Moderate Varus, Valgus or Flexion Deformities 2
Moderate-to-severe Acute Pain 1
Moderate-to-Severe Atopic Dermatitis 5
Moderate-to-severe Chronic Low Back Pain 1
Moderate-to-severe Chronic Plaque Psoriasis 4
Moderated-high Risk of Postoperative Pulmonary Complication 1
Moderately Overweight Individuals 1
Moderately to Severely Active Crohn Disease 1
Moderately to Severely Active Crohn's Disease 4
Moderately to Severely Active Ulcerative Colitis 3
MODY2 Diabetes 1
Mohs Micrographic Surgery 3
Mohs Surgery 1
Molar Incisor Hypomineralization 1
Mold Infection 1
Molecular Impact of Psychological Stress and Socioeconomic Adversity 1
Molecular Mechanisms of Pharmacological Action 3
Molecular-bacterial Vaginosis 1
Molluscum Contagiosum 2
MONITOR 1
Monitored Anesthesia Care 1
Monitoring 1
Monitoring, Physiologic 1
Monkeypox 4
Monkeypox (Mpox) 1
Mono 1
Mono or Bi-cortical Osteotomies in the Forefoot 1
Monochorial Monoamniotic Placenta 1
Monochorionic Diamniotic Placenta 2
Monoclonal 1
Monoclonal Antibody 2
Monoclonal Antibody, Human 1
Monoclonal B-Cell Lymphocytosis 4

Related

Data sourced from official public datasets. See our methodology for details.